Outpatient pharmacological company CleanSlate secured $25 million in a recent financing round led by HealthQuest Capital, which joins existing controlling investor Granite Growth Health Partners.
Founded in 2009 in response to the country’s growing opioid epidemic, CleanSlate says its addiction treatment program is grounded in the latest science and best practices, and follows guidelines set by the American Society of Addiction Medicine. Its physician-led centers are designed to provide individualized, evidence-based treatment for substance abuse, including pharmacological treatment supported by ancillary counseling. CleanSlate strives to partner with healthcare providers, health insurers, government entities, and communities.
The company says its funding will be used to accelerate its growth – 45 centers currently operate across eight states, with another 22 centers slated to open this year, and 30,000 patients treated with evidence-based medicine.